Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine

MON, MARÍA LAURA; DELGADO, FERNANDO OSCAR; CUERDA, MARÍA XIMENA; MOYANO, ROBERTO DAMIÁN; ALVARADO PINEDO, MARÍA FIORELLA; ALONSO, MARÍA NATALIA; ROMANO, MARÍA ISABEL; COLOMBATTI OLIVIERI, MARÍA ALEJANDRA; GRAVISACO, MARÍA JOSÉ; HERNÁNDEZ PANDO, ROGELIO; SANTANGELO, MARÍA DE LA PAZ

VACCINE

ELSEVIER SCI LTD

Lugar: Amsterdam; Año: 2021 vol. 39 p. 7401 - 7412

0264-410X

Bovine paratuberculosis is one of the most important chronic infectious diseases in livestock. This disease is difficult to control because of its inefficient management (test and cull strategy and inadequate biosecurity). Thus, the development of an effective vaccine is essential. In this study, we evaluated a local virulent strain (6611) of Mycobacterium avium subsp. paratuberculosis as an inactivated vaccine in comparison with the Silirum vaccine in mouse model and cattle. Regarding the mice model, only the groups vaccinated with 6611 showed lower colony forming unit (CFU) counts with a lower lesion score in the liver in comparison to the control group at 6 and 12 weeks post-challenge (wpc). The immune response was predominantly humoral (IgG1), although both vaccinated groups presented a cellular response with IFNγ production as well, but the 6611 group had also significant production of IL-2, IL-6, IL-17a, TNF, and IL-10. In cattle, the 6611 vaccinated group was the only one that maintained significant antibody values at the end of the trial, with significant production of IgG2 and IFNγ. No PPDb reactor was detected in the vaccinated animals, according to the intradermal caudal fold tuberculin test. Our results indicate that the 6611 local strain protected mice from challenge with a virulent strain, by inducing a humoral and cellular immune response. In the bovine, the natural host, the evaluated vaccine also induced humoral and cellular immune responses, with higher levels of CD4 + CD25+ and CD8 + CD25+ T cells populations than the commercial vaccine. Despite the encouraging results obtained in this study, an experimental challenge trial in cattle is mandatory to evaluate the efficacy of our candidate vaccine in the main host.